Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Tackling Unmet Needs with a Proprietary Platform

Posted on November 22nd, 2018 by in Pharma R&D

Since our founding back in 2006, LegoChem Biosciences (LCB) has focused on the research and development of anti-biotic, anti-coagulant, anti-fibrosis and Antibody-Drug Conjugate (ADC) therapeutics based on our proprietary platform technology, LegoChemistry™ & Conjuall™. LCB is comprised of researchers who have varied backgrounds and R&D experiences, including the development of Factive, the first US FDA-approved drug developed in Korea. (more…)

Introducing the Hive’s newest class of innovative start-ups

Posted on February 14th, 2018 by in The Hive

In 2017, Elsevier introduced a new program called The Hive, an innovation initiative for biotech and pharmaceutical start-ups committed to promoting collaboration and inspiration across the Pharma & Life Sciences industry.

(more…)

As The Hive Evolves, More Companies Prepare to Join the Program

Posted on December 11th, 2017 by in Pharma R&D

This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive (more…)

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by in Pharma R&D

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 7